AC Immune (ACIU) Assets Average (2016 - 2026)

AC Immune (ACIU) has reported Assets Average for 10 consecutive years, with $87.8 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Assets Average rose 35151.09% year-over-year to $87.8 billion; the TTM figure through Mar 2026 stood at $87.8 billion (up 35151.09% YoY), while the FY2025 annual figure was $224.8 million, down 4.27% from the prior year.
• Assets Average grew to $87.8 billion in Q1 2026 per ACIU's latest filing, from $203.8 million in the prior quarter.
• Across five years, Assets Average topped out at $87.8 billion in Q1 2026 and bottomed at $240054.7 in Q2 2022.
• Historically, Assets Average has averaged $5.3 billion across 5 years, with a median of $202.9 million in 2022.
• Annual changes were most pronounced in 2023 — Assets Average jumped 74181.33% — and 2025, when it fell 25.29%.
• AC Immune's Assets Average stood at $202.9 million in 2022, then declined by 9.33% to $184.0 million in 2023, then soared by 48.24% to $272.8 million in 2024, then declined by 25.29% to $203.8 million in 2025, then surged by 43009.42% to $87.8 billion in 2026.
• Business Quant data shows ACIU's Assets Average at $87.8 billion in Q1 2026, $203.8 million in Q4 2025, and $222.1 million in Q3 2025.